Research Article
Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
Table 2
Comparison of characteristics of cirrhotic patients with ascites, acute gastrointestinal hemorrhage, ACLF, and without decompensating events.
| Variables | With ascites | With acute gastrointestinal hemorrhage | With ACLF | No. Pts | ; median (range) or frequency (percentage) | value | No. Pts | ; median (range) or frequency (percentage) | value | No. Pts | ; median (range) or frequency (percentage) | value |
| Sex (male/female), (%) | 96 | 64 (66.67%)/32 (33.33%) | 0.064 | 86 | 56 (65.12%)/30 (34.88%) | 0.039 | 10 | 8 (80%)/2 (20%) | 0.558 | Age (years) | 96 | ; 60.00 (48.00-65.75) | 0.027 | 86 | ; 54.00 (45.00-63.25) | 0.692 | 10 | ; 48.00 (45.00-57.00) | 0.429 | Red blood cell (1012/L) | 96 | ; 3.08 (2.57-3.83) | <0.001 | 86 | ; 2.75 (2.39-3.35) | <0.001 | 10 | ; 2.60 (1.78-3.45) | <0.001 | Hemoglobin (g/L) | 96 | ; 93.00 (70.00-113.75) | <0.001 | 86 | ; 76.00 (66.00-99.00) | <0.001 | 10 | ; 98.50 (65.25-117.25) | 0.018 | Hematocrit (%) | 96 | ; 28.40 (21.38-34.33) | <0.001 | 86 | ; 23.15 (20.33-30.20) | <0.001 | 10 | ; 28.80 (18.58-34.75) | 0.004 | White blood cell (109/L) | 96 | ; 3.85 (2.73-6.18) | 0.119 | 86 | ; 3.60 (2.38-6.30) | 0.390 | 10 | ; 6.15 (4.43-8.25) | 0.021 | Platelet count (109/L) | 96 | ; 78.00 (54.00-106.75) | 0.384 | 86 | ; 72.50 (51.00-103.75) | 0.755 | 10 | ; 64.50 (39.00-97.25) | 0.562 | Total bilirubin (μmol/L) | 96 | ; 28.90 (15.38-63.15) | 0.186 | 86 | ; 19.55 (13.20-32.20) | 0.292 | 10 | ; 166.20 (121.25-223.50) | <0.001 | Direct bilirubin (μmol/L) | 96 | ; 13.45 (6.43-37.53) | 0.039 | 86 | ; 8.45 (5.40-16.23) | 0.582 | 10 | ; 105.10 (82.08-184.23) | <0.001 | Alanine aminotransferase (U/L) | 96 | ; 23.09 (16.25-39.37) | 0.517 | 86 | ; 20.92 (14.62-36.63) | 0.132 | 10 | ; 51.43 (23.77-63.76) | 0.012 | Aspartate aminotransferase (U/L) | 96 | ; 34.56 (24.01-68.95) | 0.404 | 86 | ; 27.45 (20.43-48.41) | 0.232 | 10 | ; 93.55 (65.65-128.31) | <0.001 | Alkaline phosphatase (U/L) | 96 | ; 101.99 (75.12-149.67) | 0.621 | 86 | ; 81.09 (59.99-110.37) | 0.019 | 10 | ; 137.08 (84.14-169.98) | 0.202 | Gamma-glutamyl transpeptidase (U/L) | 96 | ; 46.21 (21.10-108.21) | 0.901 | 86 | ; 29.01 (16.74-57.98) | 0.032 | 10 | ; 67.05 (37.05-97.91) | 0.218 | Albumin (g/L) | 96 | ; 29.65 (25.10-33.40) | <0.001 | 86 | ; 31.10 (25.68-36.18) | <0.001 | 10 | ; 22.80 (19.95-26.98) | <0.001 | Blood urea nitrogen (mmol/L) | 96 | ; 6.05 (4.42-7.86) | 0.007 | 86 | ; 6.25 (4.39-8.46) | 0.003 | 10 | ; 6.26 (4.78-11.15) | 0.070 | Creatinine (μmol/L) | 96 | ; 63.55 (53.23-82.68) | 0.686 | 86 | ; 65.86 (52.78-75.94) | 0.895 | 10 | ; 61.15 (52.53-101.95) | 0.763 | eGFR (mL/min/1.73 m2) | 96 | ; 104.38 (77.60-133.84) | 0.047 | 86 | ; 108.07 (86.83-138.32) | 0.247 | 10 | ; 107.84 (73.24-137.83) | 0.403 | Na (mmol/L) | 96 | ; 137.75 (134.93-140.95) | 0.041 | 86 | ; 139.35 (136.55-141.03) | 0.741 | 10 | ; 135.20 (131.55-139.15) | 0.021 | Prothrombin time (second) | 96 | ; 17.15 (15.60-20.45) | 0.001 | 86 | ; 16.90 (15.20-19.10) | 0.026 | 10 | ; 22.85 (20.65-27.95) | <0.001 | Activated partial thromboplastin time (second) | 96 | ; 41.90 (37.73-47.28) | 0.987 | 86 | ; 39.70 (36.98-43.98) | 0.064 | 10 | ; 52.85 (46.63-55.95) | <0.001 | International normalized ratio | 96 | ; 1.40 (1.25-1.75) | 0.001 | 86 | ; 1.37 (1.21-1.60) | 0.031 | 10 | ; 1.99 (1.77-2.59) | <0.001 | D-dimer (mg/L) | 95 | ; 2.28 (0.93-4.64) | <0.001 | 83 | ; 1.43 (0.58-3.57) | 0.001 | 9 | ; 4.51 (3.41-9.02) | <0.001 | High-sensitivity C-reactive protein (mg/L) | 95 | ; 6.90 (2.20-20.30) | 0.001 | 85 | ; 4.50 (1.20-11.55) | 0.071 | 10 | ; 30.65 (11.35-75.35) | <0.001 | MELD score | 96 | ; 13.50 (10.07-18.23) | 0.001 | 86 | ; 10.65 (9.13-14.42) | 0.343 | 10 | ; 28.14 (21.24-30.04) | <0.001 | Child-Pugh score | 96 | ; 8.00 (7.00-10.00) | <0.001 | 86 | ; 7.00 (6.00-8.00) | <0.001 | 10 | ; 12.00 (11.75-13.00) | <0.001 | NT-pro BNP (pg/mL) | 87 | ; 165.20 (71.06-415.80) | <0.001 | 78 | ; 144.95 (60.82-443.93) | <0.001 | 10 | ; 212.30 (150.70-1662.75) | <0.001 | High-sensitivity cardiac troponin T (ng/mL) | 92 | ; 0.008 (0.005-0.014) | 0.002 | 81 | ; 0.009 (0.005-0.014) | 0.003 | 9 | ; 0.007 (0.005-0.035) | 0.157 | Creatine kinase (U/L) | 95 | ; 69.00 (45.00-97.00) | 0.099 | 84 | ; 69.00 (40.50-105.50) | 0.117 | 10 | ; 71.50 (41.25-109.00) | 0.501 | Creatine kinase MB (U/L) | 95 | ; 29.00 (20.00-42.00) | 0.463 | 84 | ; 29.50 (19.00-43.75) | 0.552 | 10 | ; 22.50 (14.50-36.00) | 0.163 | Lactate dehydrogenase (U/L) | 95 | ; 195.00 (154.00-232.00) | 0.076 | 84 | ; 171.00 (140.00-206.25) | 0.727 | 10 | ; 235.00 (157.50-317.25) | 0.050 |
|
|
Bold font indicates statistically significant values. Abbreviations: ACLF: acute-on-chronic liver failure; eGFR: the estimated glomerular filtration rate; MELD: model for end-stage liver disease; NT-pro BNP: N-Terminal pro-B-type natriuretic peptide. |